Hematotoxin producing snakes in Thailand พญ.ม ชฌ มา รอดเช อ พญ.อ สร ย หาญอ ท ยร ศม

Size: px
Start display at page:

Download "Hematotoxin producing snakes in Thailand พญ.ม ชฌ มา รอดเช อ พญ.อ สร ย หาญอ ท ยร ศม"

Transcription

1 Hematotoxin producing snakes in Thailand พญ.ม ชฌ มา รอดเช อ พญ.อ สร ย หาญอ ท ยร ศม

2 Hematotoxin producing snakes Pit vipers (Crotalinae) Malayan pit viper (Calloselasma rhodostoma) Green pit viper (Trimeresurus spp.) Vipers (Viperinae) Russell s viper (Daboia russelli siamensis)

3 Malayan s pit viper

4 Green pit viper

5 Pathogenesis-Pit viper Thrombin-like effect Fibrinolytic effect Thrombocytopenia/platelet dysfunction

6

7

8

9

10 Thrombin effects Cleaving both fibrinopeptide A (FPA) and fibrinopeptide B (FPB) from fibrinogen Activating factor XIII

11 Snake venom thrombin-like enzymes (SVTLEs) Serine protease Stimulate fibrin formation Usually cleave fibrinopeptide A only Do not activate factor XIII

12

13 Thrombin-like effects Ineffective fibrin polymers Easily to break down Failure of clot cross-linking Destruction by fibrinolytic system Effective removal of fibrinogen from plasma Defibrination, Defibrinogenation Fibrinogenolytic enzyme

14 Fibrinolytic effect Fibrin deposition Tissue-type plasminogen activator GPV-Plasminogen activator

15 GPVplasminogen activator

16 Direct venom effect C-type lectins Thrombocytopenia/ platelet dysfunction Alboaggregin A, Alboaggregin B10 Prevent platelet aggregation Inhibition of surface glycoprotein receptors

17 Russell s viper

18 Pathogenesis-Viper Thromboplastin-like activity Hemolysis: Phospholipase A2

19 Thromboplastin-like factors Russell s viper venom activates Factor V, Factor X (RVV-V, RVV-X) Stimulate common hemostatic pathway Classic disseminated intravascular coagulopathy (DIC)

20

21 Laboratory investigation

22

23 PT

24 APTT

25 Whole blood clotting time (WBCT) The whole blood clotting time (WBCT) is the most frequently carried out coagulation test as an indicator for venom-induce coagulopathy Cheap Simple Bed-side test

26 Whole blood clotting time (WBCT) This test was originally described by Lee and White in 1913 In 1999, the World Health Organization (WHO) recommended another version of the WBCT, known as the 20 minutes WBCT (20WBCT)

27

28

29

30

31 Results 109 patients 12 individuals were excluded 97 patients Adult >15 years Bitten by presumed green pit viper within 72 hours ED or snakebite clinic, King Chulalongkorn Memorial Hospital OCT 2008-DEC 2010 Unknown snake (7), cirrhosis (2), current warfarin intake (2), inadequate specimen (1) Mean age 46.1 (15-82) years, 48 (49.5%) men 12 (12.4%) patients received antivenom VCT>30 min without bleeding (9), marked oedema (3)

32 Conventional VCT: highest correlation coefficient with fibrinogen level PT and INR: highest area under the ROC curve APTT: less able to distinguish hypofibrinogenaemic patient from others

33 Diagnostic accuracy of 20WBCT and INR was superior than VCT (>30 min), and APTT PT (INR): not sensitive when use fibrinogen cut off level of 1.7 g/l

34 Results 3 patients had fibrinogen level <1.0 g/l but <30 min VCT, no one receive antivenom Followed for 3 days with daily VCT Normal without clinical bleeding None reported late any late complication

35 Discussion PT prolongation (INR>1.2): related to severe hypofibrinogenaemia (fibrinogen level<1g/l) Causes of PT prolongation Low fibrinogen Hyperfibrinolysis releasing fibrin degradation products (FDPs)=> interfere with fibrin polymerization PT normal in mild hypofibrinogenaemia, low sensitivity for cut off fibrinogen of 1.7g/L

36 Discussion APTT low diagnostic accuracy Inter-laboratory variation of universal cut off level 20WBCT Confirmed accuracy in predicting severe hypofibrinogenemia in this study However, this study included fewer 20WBCT than PT and VCT

37 Discussion Conventional VCT Low sensitivity for hypofibrinogenaemia (VCT>30 min) Depend on Fibrinogen quantity FDP levels from fibrinolysis Operator dependent

38 Conclusion PT or 20WBCT can be used for evaluation of green pit viper bitten patient Depending on testing convenience and availability Prolongation of either test suggests severe hypofibrinogenaemia that requires antivenom therapy

39 Thank you

Coagulopathy Case-2. Andy Nguyen, M.D. 2009

Coagulopathy Case-2. Andy Nguyen, M.D. 2009 Coagulopathy Case-2 Andy Nguyen, M.D. 2009 CLINICAL HISTORY A 42 year-old man brought to the emergency room with severe burn. Patient was rescued by firemen in a serious fire. He had been found unconscious

More information

Local vasoconstriction. is due to local spasm of the smooth muscle (symp. reflex) can be maintained by platelet vasoconstrictors

Local vasoconstriction. is due to local spasm of the smooth muscle (symp. reflex) can be maintained by platelet vasoconstrictors Hemostasis Hemostasis ( hemo =blood; sta= remain ) is the stoppage of bleeding, which is vitally important when blood vessels are damaged. Following an injury to blood vessels several actions may help

More information

General Principles of. Hemostasis. Kristine Krafts, M.D.

General Principles of. Hemostasis. Kristine Krafts, M.D. General Principles of Hemostasis Kristine Krafts, M.D. Hemostasis is a balancing act! pro-ting plugs up holes in blood vessels anti-ting keeps ting under control Pro-Clotting Pro-Clotting vessels platelets

More information

Coagulation Mechanisms Dr. Nervana Bayoumy

Coagulation Mechanisms Dr. Nervana Bayoumy Coagulation Mechanisms Dr. Nervana Bayoumy Associate Professor Department of Physiology Objectives At the end of this lecture you should be able to: 1. Recognize the different clotting factors 2. Understand

More information

Plasma Testing in the Clinical Coagulation Laboratory: New drugs, new problems.

Plasma Testing in the Clinical Coagulation Laboratory: New drugs, new problems. Test Plasma Testing in the Clinical Coagulation Laboratory: New drugs, new problems. Karen A. Moffat BEd, MSc, ART, FCSMLS(D) Technical Specialist, Coagulation, HRLMP Assistant Professor, Department of

More information

Basic coagulation applications and case studies

Basic coagulation applications and case studies Basic coagulation applications and case studies Jing Jin Clinical laboratory Scientist (MLS, ASCP) - Coagulation/Hematology Stanford University Hospital and Clinics 1 Agenda Overview about 3 major phases

More information

Primary hemostasis. Vascular endothelium Vasoconstriction : local tissue factor, nervous system

Primary hemostasis. Vascular endothelium Vasoconstriction : local tissue factor, nervous system Primary hemostasis Vascular endothelium Vasoconstriction : local tissue factor, nervous system Platelet Plug Platelet Adhesion Platelet Activation Platelet Aggregation Platelet Plug Formation Secondary

More information

LABORATORY APPROACH TO BLEEDING DISORDERS DR NISHANTH PG 1 ST YEAR DEPARTMENT OF PATHOLOGY

LABORATORY APPROACH TO BLEEDING DISORDERS DR NISHANTH PG 1 ST YEAR DEPARTMENT OF PATHOLOGY LABORATORY APPROACH TO BLEEDING DISORDERS DR NISHANTH PG 1 ST YEAR DEPARTMENT OF PATHOLOGY 1 WHEN IS THE LAB REQUIRED TO INVESTIGATE FOR A POSSIBLE BLEEDING DISORDER? Clinically suspected bleeding tendency

More information

SEED Coagulation. Sysmex Educational Enhancement and Development April 2014

SEED Coagulation. Sysmex Educational Enhancement and Development April 2014 SEED Coagulation Sysmex Educational Enhancement and Development April 2014 The Thrombin Time Test and Reptilase Test what is their role in coagulation testing? Baseline screening tests of coagulation The

More information

ROTEM Basic Interpretation Guide

ROTEM Basic Interpretation Guide ROTEM Basic Interpretation Guide Parameter: Clotting Time CT - Clotting Time (seconds) The time from the start of the test until first significant levels of a clot are detected. This measurement is initiated

More information

Sysmex Educational Enhancement and Development No

Sysmex Educational Enhancement and Development No SEED Haematology Sysmex Educational Enhancement and Development No 3 2014 The Thrombin Time test and Reptilase test what is their role in coagulation testing? The purpose of this newsletter is to provide

More information

The Role Of Point of Care Coagulation Testing (POCCT) in Patient Blood Management. Elham Khalaf Adeli

The Role Of Point of Care Coagulation Testing (POCCT) in Patient Blood Management. Elham Khalaf Adeli The Role Of Point of Care Coagulation Testing (POCCT) in Patient Blood Management Elham Khalaf Adeli Overview PBM, bleeding management, Coagulation POC Testing Review of laboratory conventional coagulation

More information

Use of ROTEM from the Laboratory Perspective. A/Prof David Roxby SA Pathology

Use of ROTEM from the Laboratory Perspective. A/Prof David Roxby SA Pathology Use of ROTEM from the Laboratory Perspective A/Prof David Roxby SA Pathology What s the Problem? Constant changes in treatment recommendations Lack of good evidence to guide practice Variations in clinical

More information

Index. Autoimmune thrombocytopenic purpura (AITP), 100, 102, 105, 108, 187 Automated platelet counters, , 108

Index. Autoimmune thrombocytopenic purpura (AITP), 100, 102, 105, 108, 187 Automated platelet counters, , 108 A Accuracy, 6, 7, 15, 46, 52, 53, 61, 75, 100, 143, 144, 149, 166, 176, 178 Acquired coagulation disorders, 111 115 Acquired platelet disorders, 99 108 ACT. See Activated clotting time (ACT) Activated

More information

Introduction Hemostasis: Tourniquet Test & Bleeding Time. Hematology-Immunology System Faculty of Medicine Universitas Padjadjaran LOGO

Introduction Hemostasis: Tourniquet Test & Bleeding Time. Hematology-Immunology System Faculty of Medicine Universitas Padjadjaran LOGO Introduction Hemostasis: Tourniquet Test & Bleeding Time Hematology-Immunology System Faculty of Medicine Universitas Padjadjaran LOGO Hemostasis A series of reactions that function to stop bleeding, maintaining

More information

These handouts are only meant as a guide while you follow the presentation on the screen. Sometimes the speaker will change some of the slides.

These handouts are only meant as a guide while you follow the presentation on the screen. Sometimes the speaker will change some of the slides. These handouts are only meant as a guide while you follow the presentation on the screen. Sometimes the speaker will change some of the slides. If you would like the 1 slide per page handouts, please ask

More information

Coagulation. Coagulation Limited CGL, CGDF Surveys & Anatomic Pathology Education Programs. Coagulation 117

Coagulation. Coagulation Limited CGL, CGDF Surveys & Anatomic Pathology Education Programs. Coagulation 117 www.cap.org Coagulation Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Serviced (CMS). Coagulation Limited CGL, CGDF Analyte CGL CGDF New

More information

Differential effects of the direct thrombin inhibitor dabigatran etexilate vs warfarin on platelet function

Differential effects of the direct thrombin inhibitor dabigatran etexilate vs warfarin on platelet function Differential effects of the direct thrombin inhibitor dabigatran etexilate vs warfarin on platelet function Giulia Renda 1, Gelsomina Malatesta 1, Valentina Bucciarelli 1, Alessia Napoleone 1, Loredana

More information

Princess Alexandra Hospital Emergency Department. Clinical Procedure. 1 Introduction

Princess Alexandra Hospital Emergency Department. Clinical Procedure. 1 Introduction Princess Alexandra Hospital Emergency Department Clinical Procedure Trauma, Resuscitation Review Officer: Glenn Ryan 1 Introduction Version no: 1 Approval Date: 16/07/2014 Review Date: 16/07/2016 Authority:

More information

Using TEG in the ED, OR, and ICU. Don H. Van Boerum, MD, FACS

Using TEG in the ED, OR, and ICU. Don H. Van Boerum, MD, FACS Using TEG in the ED, OR, and ICU Don H. Van Boerum, MD, FACS Trauma Surgeon, Director of Surgical Critical Care, Co-Director of Shock Trauma ICU, Intermountain Medical Center, Intermountain Healthcare

More information

Clinical Procedure. ROTEM Trauma, Resuscitation. Princess Alexandra Hospital Emergency Department. 1 Introduction

Clinical Procedure. ROTEM Trauma, Resuscitation. Princess Alexandra Hospital Emergency Department. 1 Introduction Princess Alexandra Hospital Emergency Department Clinical Procedure Trauma, Resuscitation Review Officer: Glenn Ryan 1 Introduction Version no: 1 Approval Date: 16/07/2014 Review Date: 16/07/2016 Authority:

More information

ANEMIA. Oral iron. IV iron gluconate (order set #233)

ANEMIA. Oral iron. IV iron gluconate (order set #233) PREVENTION ANEMIA Oral iron IV iron gluconate (order set #233) TRANSEXAMIC ACID Efficacy of IV TXA in Reducing Blood Loss After Elective C-section: Prospective, Randomized, Double-blind, Placebo Controlled

More information

Postpartum Haemorrhage make sure you give enough fibrinogen!

Postpartum Haemorrhage make sure you give enough fibrinogen! Postpartum Haemorrhage make sure you give enough fibrinogen! Disclaimer / Pre-amble These cases have been de-identified to protect the identity of the patient and the treating teams. These are all real

More information

Evaluation of Complex Coagulation Cases: Case-Based Illustrations of Important Issues

Evaluation of Complex Coagulation Cases: Case-Based Illustrations of Important Issues Evaluation of Complex Coagulation Cases: Case-Based Illustrations of Important Issues Kristi J. Smock, MD Associate Professor of Pathology University of Utah Health Sciences Center Medical Director, Hemostasis/Thrombosis

More information

2 Thomas G. DeLoughery

2 Thomas G. DeLoughery Tests of Hemostasis and Thrombosis 2 Thomas G. DeLoughery A routine laboratory test once well-established is often slavishly adhered to, with little further thought about how it originated, why it is done

More information

DEPARTMENT OF CLINICAL LABORATORY SCIENCES SCHOOL OF HEALTH TECHNOLOGY AND MANAGEMENT THE UNIVERSITY AT STONY BROOK STONY BROOK, NEW YORK

DEPARTMENT OF CLINICAL LABORATORY SCIENCES SCHOOL OF HEALTH TECHNOLOGY AND MANAGEMENT THE UNIVERSITY AT STONY BROOK STONY BROOK, NEW YORK DEPARTMENT OF CLINICAL LABORATORY SCIENCES SCHOOL OF HEALTH TECHNOLOGY AND MANAGEMENT THE UNIVERSITY AT STONY BROOK STONY BROOK, NEW YORK 11794-8205 COAGULATION COMPETENCY EVALUATION FORM STUDENT NAME:

More information

Category Storage Shelf Life Additional Criteria

Category Storage Shelf Life Additional Criteria CE Update [blood banking/transfusion medicine] Blood Components for Hemostasis Jun Teruya, MD, DSc, and Glenn Ramsey, MD From the Department of Pathology, Northwestern University Medical School, Chicago.

More information

Coagulation in perspective: Blood management. Objectives

Coagulation in perspective: Blood management. Objectives Coagulation in perspective: Blood management Julie Wegner, PhD jawrbl@gmail.com Objectives To gain a basic understanding of the following: 1. Coagulation components and processes Why patients bleed. 2.

More information

EDUCATIONAL COMMENTARY STRAIGHT TALK ABOUT THE D-DIMER

EDUCATIONAL COMMENTARY STRAIGHT TALK ABOUT THE D-DIMER EDUCATIONAL COMMENTARY STRAIGHT TALK ABOUT THE D-DIMER Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits

More information

Applying ROTEM to the Management of Bleeding in Trauma

Applying ROTEM to the Management of Bleeding in Trauma Applying ROTEM to the Management of Bleeding in Trauma Sandro Rizoli, MD PhD FRCSC FACS Professor Surgery & Critical Care Medicine Trauma Program Director Chair Trauma Care Disclosure NONE ROTEM Growing

More information

Haemostasis. The function of haemostasis is: to prevent blood loss from injured vessels. to stop bleeding. to prevent thrombosis

Haemostasis. The function of haemostasis is: to prevent blood loss from injured vessels. to stop bleeding. to prevent thrombosis Haemostasis Haemostasis The function of haemostasis is: to prevent blood loss from injured vessels to stop bleeding to prevent thrombosis Haemostasis blood endothelium basement membrane subendothelium

More information

Activated Protein C Resistance vs Factor V Leiden assay: Which is the most cost effective?

Activated Protein C Resistance vs Factor V Leiden assay: Which is the most cost effective? Activated Protein C Resistance vs Factor V Leiden assay: Which is the most cost effective? Rajiv K. Pruthi, M.B.B.S Co-Director, Special Coagulation Laboratory & Director, Mayo Comprehensive Hemophilia

More information

Disseminated Intravascular Coagulopathy

Disseminated Intravascular Coagulopathy REVIEW ARTICLE Disseminated Intravascular Coagulopathy Lt Col Rajat Kumar Introduction Disseminated Intravascular Coagulopathy (DIC) is an acquired disorder which, in its mildest form is only an aberration

More information

Alternative Haemostatic Agents in the Management of Obstetric Haemorrhage

Alternative Haemostatic Agents in the Management of Obstetric Haemorrhage Alternative Haemostatic Agents in the Management of Obstetric Haemorrhage Clinical Associate Professor Nolan McDonnell School of Medicine and Pharmacology, School of Women s and Infants Health University

More information

EDUCATIONAL COMMENTARY D-DIMER UPDATE

EDUCATIONAL COMMENTARY D-DIMER UPDATE EDUCATIONAL COMMENTARY D-DIMER UPDATE Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits see the Continuing

More information

Physiology Unit 3 HEMATOLOGY

Physiology Unit 3 HEMATOLOGY Physiology Unit 3 HEMATOLOGY In Physiology Today Hematocrit Percentage of blood volume that is erythrocytes 45% in men 42% in women Average blood volume in is 5 L Plasma Large amounts of organic/inorganic

More information

Session 1 Topics. Vascular Phase of Hemostasis. Coagulation Pathway. Action of Unfractionated Heparin. Laboratory Monitoring of Anticoagulant Therapy

Session 1 Topics. Vascular Phase of Hemostasis. Coagulation Pathway. Action of Unfractionated Heparin. Laboratory Monitoring of Anticoagulant Therapy ~~Marshfield Labs Presents~~ Laboratory Monitoring of Anticoagulant Therapy Session 1 of 4 Session 1 Topics Review of coagulation and the vascular phase of hemostasis Unfractionated heparin Low molecular

More information

Laboratory Monitoring of Anticoagulation

Laboratory Monitoring of Anticoagulation Michael Smith, Pharm. D., BCPS, CACP East Region Pharmacy Clinical Manager Hartford HealthCare Learning Objectives Explain the role of common laboratory tests used in monitoring of anticoagulation therapy.

More information

LABORATORY APPROCH TO THE BLEEDING PATIENT

LABORATORY APPROCH TO THE BLEEDING PATIENT Anne Winkler, MD Emory University School of Medicine, Atlanta Georgia Assistant Professor, Pathology & Laboratory Medicine Medical Director, Transfusion Service, Grady Health System Assistant Director,

More information

Laboratory investigation in the Bleeding Patient. Dr Craig Taylor Consultant Haematologist May 2016

Laboratory investigation in the Bleeding Patient. Dr Craig Taylor Consultant Haematologist May 2016 Laboratory investigation in the Bleeding Patient Dr Craig Taylor Consultant Haematologist May 2016 Introduction Bleeding is common May consume significant resources Crossmatched blood Lab results may be

More information

HaematologY. Dr Tom Bate Again!

HaematologY. Dr Tom Bate Again! HaematologY Dr Tom Bate Again! THE FRCA What you need to know Blood Groups ~30 blood group systems recognised (ISBT) ABO, Rhesus, Lewis, Kell, Duffy, Kidd MNS system, Kell system The ABO antigens are the

More information

P. W. HOWIE M.D., M.R.C.O.G. first method of activation is the intrinsic system. Hageman factor, which in turn activates a series of

P. W. HOWIE M.D., M.R.C.O.G. first method of activation is the intrinsic system. Hageman factor, which in turn activates a series of Postgraduate Medical Journal (May 1979) 55, 362-366 Blood clotting and fibrinolysis in pregnancy P. W. HOWIE M.D., M.R.C.O.G. MRC Unit of Reproductive Biology, Edinburgh Summary During normal pregnancy,

More information

Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction with lumbrokinase

Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction with lumbrokinase Clinical Hemorheology and Microcirculation 23 (2000) 213 218 213 IOS Press Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction with lumbrokinase Lirong Jin

More information

ROZAIMAH ZAIN-HAMID. Department of Pharmacology and Therapeutics Faculty of Medicine, Universitas Sumatera Utara

ROZAIMAH ZAIN-HAMID. Department of Pharmacology and Therapeutics Faculty of Medicine, Universitas Sumatera Utara ROZAIMAH ZAIN-HAMID Department of Pharmacology and Therapeutics Faculty of Medicine, Universitas Sumatera Utara Drugs Used in Disorders of Coagulation Fibrinolytic drugs Anti-thrombotic thrombotic drugs

More information

ROTEM delta. Targeted therapy stops the bleeding. Easy and safe handling Fast therapeutic decisions Advanced diagnostic safety

ROTEM delta. Targeted therapy stops the bleeding. Easy and safe handling Fast therapeutic decisions Advanced diagnostic safety ROTEM delta Targeted therapy stops the bleeding. Easy and safe handling Fast therapeutic decisions Advanced diagnostic safety ROTEM delta haemostasis analyser Complicated bleeding situations can appear

More information

Hematology Emergencies: Problems with Platelets

Hematology Emergencies: Problems with Platelets Hematology Emergencies: Problems with Platelets Christian Cable, MD, FACP Associate Professor of Medicine Division of Hematology & Oncology Texas A&M HSC College of Medicine Scott & White Healthcare Fundamentals

More information

Residual Serum Thrombin

Residual Serum Thrombin Residual Serum Thrombin Activity Murray Weiner N RECENT YEARS a remarkable number of blood and tissue components have been found to play a role in the formation of thrombin, the enzyme ultimately responsible

More information

Blood Product Utilization

Blood Product Utilization Who gets what & when Why not to give blood? Volume Expander For specific number (except as related to procedures) To patients with religious objections to blood transfusions Blood given only when necessary

More information

Dr. Susan Louw Haematopathologist NHLS / WITS / SASTH

Dr. Susan Louw Haematopathologist NHLS / WITS / SASTH Dr. Susan Louw Haematopathologist NHLS / WITS / SASTH Since 1948 Initially a research tool Utility in management of bleeding and thrombosis Guide clotting factor replacement, platelet / blood transfusions

More information

Hemostasis. by Mohie-Aldien Elsayed

Hemostasis. by Mohie-Aldien Elsayed Hemostasis by Mohie-Aldien Elsayed Hemostasis Hemostasis is defined as the process that maintains the flowing blood in a fluid state and confined to the circulatory system Coagulation prevents excess blood

More information

Coagulation Cascade. TF-VIIa. Tissue Factor + VII. XIIa. Prothrombin. XIa. IXa. VIIIa. Thrombin. XL- Fibrin. XIII Monomer. Fibrinogen.

Coagulation Cascade. TF-VIIa. Tissue Factor + VII. XIIa. Prothrombin. XIa. IXa. VIIIa. Thrombin. XL- Fibrin. XIII Monomer. Fibrinogen. Coagulation Cascade Intrinsic Pathway Extrinsic Pathway Contact Activation XIIa XI XIa Prekallikrein HMW Kininogen IX IXa Ca 2+ Anticoagulation proteins: Protein C, Protein S, Antithrombin III, TFPI TF

More information

Major Burns Debridement Case

Major Burns Debridement Case Major Burns Debridement Case Disclaimer / Pre-amble These cases have been de-identified to protect the identity of the patient and the treating teams. These are all real cases and real ROTEMs. The individuals

More information

Linking in silico and in vitro experiments to identify and evaluate a biomarker for enoxaparin activity

Linking in silico and in vitro experiments to identify and evaluate a biomarker for enoxaparin activity Linking in silico and in vitro experiments to identify and evaluate a biomarker for enoxaparin activity Abhishek Gulati What is enoxaparin? Low molecular weight heparin anticoagulant Used to minimise the

More information

REVIEW OF TRANEXAMIC ACID IN TRAUMA

REVIEW OF TRANEXAMIC ACID IN TRAUMA REVIEW OF TRANEXAMIC ACID IN TRAUMA At the bottom of this article are the links to a couple of pretty good recent reviews about the current state of TXA. But first a bit of background. Coagulopathy in

More information

PROTHROMBIN TIME WHY USE LOW ISI (HIGH SENSITIVITY)

PROTHROMBIN TIME WHY USE LOW ISI (HIGH SENSITIVITY) PROTHROMBIN TIME WHY USE LOW ISI (HIGH SENSITIVITY) PROTHROMBIN TIME DEFINITION The Prothrombin time is the functional determination of the extrinsic coagulation pathway. It is a widely used laboratory

More information

Special Coagulation - APC Resistance. DiaPharma Group, Inc. Customer Service: Technical Support:

Special Coagulation - APC Resistance. DiaPharma Group, Inc. Customer Service: Technical Support: Special Coagulation - APC Resistance DiaPharma Group, Inc. Customer Service: 1.800.526.5224 Technical Support:1.800.447.3846 www.diapharma.com 1 Review of Hemostasis Overview Pathways of coagulation, anticoagulation,

More information

Manejo de la transfusión de plaquetas. Ileana López-Plaza, MD

Manejo de la transfusión de plaquetas. Ileana López-Plaza, MD Manejo de la transfusión de plaquetas Ileana López-Plaza, MD Thrombocytopenia Common in ICU setting 25-38% with< 100,000/µL 2-3 % with < 10,000/µL Common etiologies Drug-induced: heparin, antibiotics,

More information

Emergency and Perioperative Hemostasis Testing: Which Assays Provide Helpful Information. Wayne Chandler, MD Laboratory Medicine Seattle Children s

Emergency and Perioperative Hemostasis Testing: Which Assays Provide Helpful Information. Wayne Chandler, MD Laboratory Medicine Seattle Children s Emergency and Perioperative Hemostasis Testing: Which Assays Provide Helpful Information Wayne Chandler, MD Laboratory Medicine Seattle Children s Emergency Hemostasis Testing Patients actively bleeding

More information

Pharmacology Lecture 5. Anticoagulants

Pharmacology Lecture 5. Anticoagulants Pharmacology Lecture 5 Anticoagulants General overview Anti-thrombotic Drugs Antiplatlets Anticoagulants Fibrinolytics Anticoagulants Indirect Thrombin Inhibitors Anti-thrombotic effect is exerted by interaction

More information

ANTITHROMBIN FACTOR Xa

ANTITHROMBIN FACTOR Xa 2014 ATITRMBI FACTR Xa The Coamatic Antithrombin kits are simple, accurate and convenient. All methods are based on inhibition. Allows accurate determination of antithrombin in patients receiving heparin

More information

Principles of Coagulation Testing. Andy Nguyen, MD 8/4/2010

Principles of Coagulation Testing. Andy Nguyen, MD 8/4/2010 Principles of Coagulation Testing Andy Nguyen, MD 8/4/2010 FSP and D-Dimer FDP vs. D-DIMER Fibrin is formed as the end result of coagulation cascade activation Fibrinolysis causes cleavage of fibrinogen,

More information

Hemostasis and Thrombosis

Hemostasis and Thrombosis Hemostasis Hemostasis and Thrombosis Normal hemostasis is a consequence of tightly regulated processes that maintain blood in a fluid state in normal vessels, yet also permit the rapid formation of a hemostatic

More information

Marcia L. Zucker, Ph.D. ZIVD LLC

Marcia L. Zucker, Ph.D. ZIVD LLC Marcia L. Zucker, Ph.D. ZIVD LLC 1 Explain why ACTs from different systems are not the same Develop a plan for switching from one ACT system to another Describe why ACT and aptt are not interchangeable

More information

DOACs: When and how to measure their anticoagulant effect

DOACs: When and how to measure their anticoagulant effect DOACs: When and how to measure their anticoagulant effect Stavroula Tsiara MD, PhD, FRCP Associate Professor of Internal Medicine University of Ioannina, Greece NOACs NOACs, TSOACs, DOACs (ISTH) Target

More information

Disclosure (s) Relevant financial relationship(s) None Off-label usage None Change in slide set You betcha! (YES!) 2015 MFMER slide-1

Disclosure (s) Relevant financial relationship(s) None Off-label usage None Change in slide set You betcha! (YES!) 2015 MFMER slide-1 Disclosure (s) Relevant financial relationship(s) None Off-label usage None Change in slide set You betcha! (YES!) 2015 MFMER slide-1 Learning Objectives Explain the concept of thrombophilia Recognize

More information

*NCCT is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. Program, provider #122.

*NCCT is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. Program, provider #122. COURSE DESCRIPTION Have you ever wondered why the blood that a phlebotomist collects in a tube will form a clot unless certain chemicals are added to the tube in advance to prevent it? Have you ever wondered

More information

WORTHAM LABORATORIES, INC. DRAFT Thrombin Reagent

WORTHAM LABORATORIES, INC. DRAFT Thrombin Reagent WORTHAM LABORATORIES, INC. DRAFT Thrombin Reagent Intended Use Wortham Laboratories Thrombin Reagent is intended for thrombin to convert fibrinogen in the quantitative determination of fibrinogen in plasma

More information

Dr Kate Talks, Consultant Haematologist, Newcastle upon Tyne Hospitals NHS Trust Nov 2012

Dr Kate Talks, Consultant Haematologist, Newcastle upon Tyne Hospitals NHS Trust Nov 2012 Dr Kate Talks, Consultant Haematologist, Newcastle upon Tyne Hospitals NHS Trust Nov 2012 What coagulation tests are needed in major haemorrhage What POCT tests are available How do you go about setting

More information

Cryoprecipitate audit within six centres in New Zealand.

Cryoprecipitate audit within six centres in New Zealand. Cryoprecipitate audit within six centres in New Zealand. Final Report Audit data collated by: Rachel Donegan : Auckland Rebecca Charman: Manukau Christopher Corkery : Hamilton Catherine Hammond :Wellington

More information

Improving Outcomes of Cardiac Surgery with a Point-of-Care Based Transfusion Algorithm

Improving Outcomes of Cardiac Surgery with a Point-of-Care Based Transfusion Algorithm Improving Outcomes of Cardiac Surgery with a Point-of-Care Based Transfusion Algorithm Summer Syed (local PI) Keyvan Karkouti Deputy Anesthesiologist-in-Chief, Toronto General Hospital, University Health

More information

Pharmacotherapy Resuscitation in Acute Traumatic Coagulopathy: Ready for Prime Time? September 29, 2017

Pharmacotherapy Resuscitation in Acute Traumatic Coagulopathy: Ready for Prime Time? September 29, 2017 Pharmacotherapy Resuscitation in Acute Traumatic Coagulopathy: Ready for Prime Time? September 29, 2017 Martha Evans, PharmD PGY-1 Pharmacy Resident Dell Seton Medical Center martha.evans@ascension.org

More information

Laboratory Investigation of Challenging Cases. Laura A. Worfolk, Ph.D Scientific Director, Coagulation

Laboratory Investigation of Challenging Cases. Laura A. Worfolk, Ph.D Scientific Director, Coagulation Laboratory Investigation of Challenging Cases Laura A. Worfolk, Ph.D Scientific Director, Coagulation Coagulation Cascade XII XIIa XI HMWK/Prekallikrein XIa VII Injury IX X IXa VIII Xa X TF TF/VIIa Prothrombin

More information

IMPORTANCE OF COAGLUOPATHIES IN COMPANION ANIMALS

IMPORTANCE OF COAGLUOPATHIES IN COMPANION ANIMALS 74 IMPORTANCE OF COAGLUOPATHIES IN COMPANION ANIMALS Urs Giger School of Veterinary Medicine, University of Pennsylvania, Philadelphia, USA Practical Tools to Approach Bleeding Patients Urs Giger, Dipl.

More information

Guideline on core SmPC for human fibrinogen products

Guideline on core SmPC for human fibrinogen products 23 July 2015 EMA/CHMP/BPWP/691754/2013 Rev 1 Committee for Medicinal Products for Human Use (CHMP) Draft Agreed by Blood Products Working Party 27 November 2013 Adoption by CHMP for release for consultation

More information

Sonoclot Analyzer User Guide

Sonoclot Analyzer User Guide Sonoclot Analyzer User Guide for Cardiopulmonary Bypass Surgery Rev 1. Sienco, Inc. 5721 Arapahoe Ave, Unit A1-A, Boulder, CO 833 USA 33-42-1148 1-8-432-1624 Fax 33-379-443 www.sienco.com e-mail: sienco@sienco.com

More information

Sign up to receive ATOTW weekly -

Sign up to receive ATOTW weekly - BLOOD PHYSIOLOGY PART 2 ANAESTHESIA TUTORIAL OF THE WEEK 231 11 TH JULY 2011 Dr Karen Hayes Royal Devon & Exeter Correspondence to: kmhayes@hotmail.co.uk QUESTIONS Before continuing, try to answer the

More information

Transfus Med Hemother 2009;36:

Transfus Med Hemother 2009;36: Transfus Med Hemother 2009;36:419 436 7 Procoagulators 7.1 Fibrinogen 7.1.1 Preparation, Quality Criteria 7.1.2 Active Constituents 7.1.3 Physiological Function 7.1.4 Application 7.1.4.1 Congenital Fibrinogen

More information

Monitoring Anticoagulation During Aprotinin Utilization

Monitoring Anticoagulation During Aprotinin Utilization Review Article Monitoring Anticoagulation During Aprotinin Utilization Jennifer Schaadt, BS, CCP Mt. Auburn Hospital, Cambridge, Massachusetts Keywords: aprotinin, cardiopulmonary bypass, heparin, anticoagulation

More information

Laboratory Monitoring of Unfractionated Heparin Therapy

Laboratory Monitoring of Unfractionated Heparin Therapy 1 PATHOLOGY & LABORATORY MEDICINE December, 2015 Laboratory Monitoring of Unfractionated Heparin Therapy On November 18, 2015, the Thrombosis and Hemostasis Laboratory transitioned from the aptt to the

More information

Sysmex Educational Enhancement & Development

Sysmex Educational Enhancement & Development Sysmex Educational Enhancement & Development SEED-Africa Newsletter No 9 2011 Quality control in coagulation testing Basic Coagulation The purpose of this newsletter is to provide an overview of internal

More information

REGIONAL AUDIT OF PLASMA PRODUCTS 2016

REGIONAL AUDIT OF PLASMA PRODUCTS 2016 REGIONAL AUDIT OF PLASMA PRODUCTS 2016 Background: In 2010, the East of England RTC carried out an audit of the use of Fresh Frozen Plasma (FFP) in adult patients. With the introductions of trauma networks

More information

Stability of Plasma for Add-On PT and APTT Tests

Stability of Plasma for Add-On PT and APTT Tests COAGULATION AND TRANSFUSION MEDICINE Original Article Stability of Plasma for Add-On PT and APTT Tests DEMETRA NEOFOTISTOS, MT, MARIA OROPEZA, MT(ASCP), AND CHUNG-HSIN TS'AO, PhD We conducted studies to

More information

Blood transfusion in special situations and poly-trauma. Dr Marina Karakantza Consultant Haematologist in Transfusion Medicine, LTHT

Blood transfusion in special situations and poly-trauma. Dr Marina Karakantza Consultant Haematologist in Transfusion Medicine, LTHT Blood transfusion in special situations and poly-trauma Dr Marina Karakantza Consultant Haematologist in Transfusion Medicine, LTHT Uncontrolled bleeding is a major preventable cause of death in trauma

More information

The Coagulation Workup In The Office Setting

The Coagulation Workup In The Office Setting CAA Conference alm Springs 2012 The Coagulation Workup In The Office Setting CAA Conference alm Springs, October 2012 Robert Miller, A-C Henoch-Schoenlein urpura 1 CAA Conference alm Springs 2012 2 CAA

More information

Marcia L. Zucker, Ph.D. ZIVD LLC

Marcia L. Zucker, Ph.D. ZIVD LLC Marcia L. Zucker, Ph.D. ZIVD LLC 1 Monitoring hemostasis Bleeding Clotting 2 Picture courtesy of Helena Laboratories 3 Extrinsic Pathway Monitor with ACT / aptt WARFARIN Monitor with PT Common Pathway

More information

Adv Pathophysiology Unit 4 Page 1 of 10. Learning Objectives for this file:

Adv Pathophysiology Unit 4 Page 1 of 10. Learning Objectives for this file: Adv Pathophysiology Unit 4 Page 1 of 10 Learning Objectives for this file: Topics include structure & function of: 1. Coagulation process platelets, clotting factors 2. Coagulation cascade formation of

More information

Ch 13: Blood. What does blood do? Transport: Regulation: Protection:

Ch 13: Blood. What does blood do? Transport: Regulation: Protection: Ch 13: Blood What does blood do? Transport: Regulation: Protection: SLOs Describe the composition of plasma and list the major functions of plasma proteins. Map hematopoiesis, starting from a pluripotent

More information

Lina Al-Lawama. Rama Al-Ashqar. Malik Al-Zohlof

Lina Al-Lawama. Rama Al-Ashqar. Malik Al-Zohlof 2 Lina Al-Lawama Rama Al-Ashqar Malik Al-Zohlof Anticoagulant drugs Recap Last lecture we were talking about antiplatelet drugs, we mentioned 5 drugs : Aspirin which is used alone with patents that have

More information

Reverse the New Anticoagulants? Mitchell J Daley, PharmD, BCPS

Reverse the New Anticoagulants? Mitchell J Daley, PharmD, BCPS Reverse the New Anticoagulants? Mitchell J Daley, PharmD, BCPS Clinical Pharmacy Specialist, Critical Care University Medical Center Brackenridge / Dell Seton Medical Center at the University of Texas

More information

Phoenix, AZ Laboratory - Test Menu

Phoenix, AZ Laboratory - Test Menu Laboratory - Menu Laboratory ame CPT Code Specimen Requirement Methodology Assay Schedule Reference Range Available ing (/) 320908 E90237 Abnormal PT/aPTT Reflexive Profile (aptt, Prothrombin Time/IR,

More information

Marcia L. Zucker, Ph.D. ZIVD LLC

Marcia L. Zucker, Ph.D. ZIVD LLC Marcia L. Zucker, Ph.D. ZIVD LLC 1 Monitoring hemostasis Bleeding Clotting 2 3 Extrinsic Pathway Monitor with ACT / aptt WARFARIN Monitor with PT Common Pathway X II Xa LMWH & DXaI IIa (thrombin) Hirudin

More information

Phoenix, AZ Laboratory - Test Menu

Phoenix, AZ Laboratory - Test Menu - Menu Laboratory umber ame CPT Code Specimen Requirement Methodology Assay Schedule Reference Range Available (/) 320908 E90237 Abnormal PT/aPTT Reflexive Profile (aptt, Prothrombin Time/IR, Thrombin

More information

Pharmacotherapy Management in Patients with Extracorporeal Membrane Oxygenation

Pharmacotherapy Management in Patients with Extracorporeal Membrane Oxygenation Pharmacotherapy Management in Patients with Extracorporeal Membrane Oxygenation Ayesha Ather, PharmD, BCPS College of Pharmacy, Adjunct Assistant Professor University of Kentucky Faculty Disclosure I have

More information

Disseminated Intravascular Coagulation: Laboratory Support for Management and Treatment

Disseminated Intravascular Coagulation: Laboratory Support for Management and Treatment Disseminated Intravascular Coagulation: Laboratory Support for Management and Treatment Virginia R. Fisher, BS, MT(ASCP), 1 Mary K. Scott, BS, MLS(ASCP) CM, 1 Christine A. Tremblay, BS, MLS(ASCP) CM, 1

More information

TSOAC Case Study 1. Question. TSOAC Case Study 1 Continued

TSOAC Case Study 1. Question. TSOAC Case Study 1 Continued TSOAC Case Study 1 An otherwise healthy 56-year-old man presents to the emergency department with left leg pain and swelling for the last 3 days. Compression ultrasonography confirms left common femoral

More information

Serine Proteases and their Inhibitors

Serine Proteases and their Inhibitors ugo Kubinyi, www.kubinyi.de Serine Proteases and their Inhibitors ugo Kubinyi Germany E-Mail kubinyi@t-online.de omepage www.kubinyi.de ugo Kubinyi, www.kubinyi.de Serine Proteases of Physiological Importance

More information

Use of Chromogenic Assay of Factor X to Accept or Reject INR Results in Warfarin Treated Patients

Use of Chromogenic Assay of Factor X to Accept or Reject INR Results in Warfarin Treated Patients CM&R Rapid Release. Published online ahead of print July 22, 2009 as Use of Chromogenic Assay of Factor X to Accept or Reject INR Results in Warfarin Treated Patients Michael J. Sanfelippo, MS, MT ASCP;

More information

CASE REPORT JOURNAL OF MEDICAL. Wada et al. Journal of Medical Case Reports 2012, 6:378

CASE REPORT JOURNAL OF MEDICAL. Wada et al. Journal of Medical Case Reports 2012, 6:378 Wada et al. Journal of Medical Case Reports 2012, 6:378 JOURNAL OF MEDICAL CASE REPORTS CASE REPORT Open Access Severe bleeding tendency caused by a rare complication of excessive fibrinolysis with disseminated

More information

Coagulation and postpartum haemorrhage. Peter Collins Cardiff

Coagulation and postpartum haemorrhage. Peter Collins Cardiff Coagulation and postpartum haemorrhage Peter Collins Cardiff Definitions and incidence Massive PPH >2500 ml blood loss (4/1000 deliveries in UK) 1 8% hysterectomy, 75% of severe maternal morbidity 1 Other

More information

Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations

Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations British Journal of Anaesthesia 101 (6): 769 73 (2008) doi:10.1093/bja/aen270 Advance Access publication September 25, 2008 Fibrinogen concentrate substitution therapy in patients with massive haemorrhage

More information